These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36907780)

  • 1. Association of Serum Fibroblast Growth Factor 23 and FGF23 Gene Variants with Chronic Kidney Disease in Patients with Type 2 Diabetes and Essential Hypertension.
    Mendoza-Carrera F; Farías-Basulto A; Gómez-García EF; Cortés-Sanabria L; Cueto-Manzano AM; Rizo-de la Torre LDC; Leal-Cortés CA
    Arch Med Res; 2023 Apr; 54(3):239-246. PubMed ID: 36907780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 23 (FGF23) gene polymorphisms are associated with essential hypertension risk and blood pressure levels in Chinese Han population.
    Cai P; Peng Y; Li L; Chu W; Wang X
    Clin Exp Hypertens; 2018; 40(7):680-685. PubMed ID: 29336609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Variants of the
    Gómez-García EF; Cortés-Sanabria L; Cueto-Manzano AM; Vidal-Martínez MA; Medina-Zavala RS; López-Leal J; Rentería-Padilla J; Mendoza-Carrera F
    Genet Test Mol Biomarkers; 2022; 26(7-8):382-390. PubMed ID: 35881855
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
    Zhao SJ; Wang ZX; Chen L; Wang FX; Kong LD
    Ann Palliat Med; 2022 Apr; 11(4):1264-1277. PubMed ID: 34775773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients.
    Kanda E; Yoshida M; Sasaki S
    BMC Nephrol; 2012 Sep; 13():122. PubMed ID: 23013306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Ying GS; Houston S; Isakova T; Nessel L; Ojo A; Go A; Lash J; Kusek J; Grunwald J; Wolf M;
    Nephrol Dial Transplant; 2015 Sep; 30(9):1534-41. PubMed ID: 25910495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of fibroblast growth factor 23 with urate metabolism in patients with chronic kidney disease.
    Sakoh T; Nakayama M; Tsuchihashi T; Yoshitomi R; Tanaka S; Katafuchi E; Fukui A; Shikuwa Y; Anzai N; Kitazono T; Tsuruya K
    Metabolism; 2016 Oct; 65(10):1498-507. PubMed ID: 27621185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony.
    Yeung SMH; Bakker SJL; Laverman GD; De Borst MH
    Curr Diab Rep; 2020 Aug; 20(10):50. PubMed ID: 32857288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of FGF19, FGF21 and FGF23 with carbohydrate metabolism parameters and insulin resistance in patients with chronic kidney disease.
    Marchelek-Mysliwiec M; Dziedziejko V; Dolegowka K; Pawlik A; Safranow K; Stepniewska J; Wisniewska M; Malyszko J; Ciechanowski K
    J Appl Biomed; 2020 Aug; 18(2-3):61-69. PubMed ID: 34907727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.
    De Jong MA; Eisenga MF; van Ballegooijen AJ; Beulens JWJ; Vervloet MG; Navis G; Gansevoort RT; Bakker SJL; De Borst MH
    Nephrol Dial Transplant; 2021 Jan; 36(1):121-128. PubMed ID: 32124925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Genetically Predicted Fibroblast Growth Factor-23 with Heart Failure: A Mendelian Randomization Study.
    Akwo E; Pike MM; Ertuglu LA; Vartanian N; Farber-Eger E; Lipworth L; Perwad F; Siew E; Hung A; Bansal N; de Boer I; Kestenbaum B; Cox NJ; Ikizler TA; Wells Q; Robinson-Cohen C
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1183-1193. PubMed ID: 35902130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23, Frailty, and Falls in SPRINT.
    Jovanovich A; Ginsberg C; You Z; Katz R; Ambrosius WT; Berlowitz D; Cheung AK; Cho M; Lee AK; Punzi H; Rehman S; Roumie C; Supiano MA; Wright CB; Shlipak M; Ix JH; Chonchol M
    J Am Geriatr Soc; 2021 Feb; 69(2):467-473. PubMed ID: 33289072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.
    Mehta R; Cai X; Lee J; Scialla JJ; Bansal N; Sondheimer JH; Chen J; Hamm LL; Ricardo AC; Navaneethan SD; Deo R; Rahman M; Feldman HI; Go AS; Isakova T; Wolf M;
    JAMA Cardiol; 2016 Aug; 1(5):548-56. PubMed ID: 27434583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
    Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.
    Czaya B; Faul C
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31461904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on serum FGF23 levels among patients with diabetic kidney disease: a randomized controlled trial.
    Triwatana W; Satirapoj B; Supasyndh O; Nata N
    Int Urol Nephrol; 2023 May; 55(5):1255-1262. PubMed ID: 36441433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.